Cellectis (CLLS) Minority Interest (2014 - 2023)
Cellectis' (CLLS) quarterly Minority Interest came in at $6.8 million in Q1 2023, down 43.76% year-on-year from $12.0 million in Q1 2022, and down 15.29% quarter-over-quarter from $8.0 million in Q4 2022.
Cellectis (CLLS) Minority Interest (2014 - 2023) Analysis & Trends
Cellectis' Minority Interest history runs 10 years deep, the most recent figure standing at $6.8 million for Q1 2023.
- On a quarterly basis, Minority Interest fell 43.76% year-over-year to $6.8 million in Q1 2023; TTM through Mar 2023 was $6.8 million, a 43.76% decrease from a year earlier, with the FY2022 full-year figure at $8.0 million, down 47.48% from the prior year.
- Minority Interest retreated to $6.8 million in Q1 2023 per CLLS's latest filing, from $8.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $41.3 million in Q2 2019 and bottomed at $6.8 million in Q1 2023.
- The 5-year median for Minority Interest is $26.5 million (2021), against an average of $26.0 million.
- Across the five-year window, Minority Interest jumped 92.19% in 2019 and sank 62.9% in 2022, its largest moves.
- Year by year, Minority Interest stood at $40.3 million in 2019, then tumbled by 37.91% to $25.1 million in 2020, then sank by 39.4% to $15.2 million in 2021, then slumped by 47.48% to $8.0 million in 2022, then declined by 15.29% to $6.8 million in 2023.
- Per Business Quant, the three latest CLLS Minority Interest figures stand at $6.8 million (Q1 2023), $8.0 million (Q4 2022), and $9.0 million (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 6.75 Mn |
| Dec 31, 2022 | 7.97 Mn |
| Sep 30, 2022 | 8.97 Mn |
| Jun 30, 2022 | 11.59 Mn |
| Mar 31, 2022 | 12.01 Mn |
| Dec 31, 2021 | 15.18 Mn |
| Sep 30, 2021 | 24.18 Mn |
| Jun 30, 2021 | 26.46 Mn |
| Mar 31, 2021 | 27.82 Mn |
| Dec 31, 2020 | 25.05 Mn |
| Sep 30, 2020 | 35.84 Mn |
| Jun 30, 2020 | 37.45 Mn |
| Mar 31, 2020 | 38.74 Mn |
| Dec 31, 2019 | 40.35 Mn |
| Sep 30, 2019 | 41.14 Mn |
| Jun 30, 2019 | 41.28 Mn |
| Mar 31, 2019 | 41.16 Mn |
| Dec 31, 2018 | 40.97 Mn |
| Sep 30, 2018 | 40.67 Mn |
| Jun 30, 2018 | 41.05 Mn |